Expression Levels of Thymidylate Synthase, Thymidylate Phosphorylase and Dihydropyrimidine Dehydrogenase in Head and Neck Squamous Cell Carcinoma: Preliminary Study
Introduction Pharyngo-laryngeal tumors classified as T3-4, N0-3, M0, are conventionally treated by mutilating surgery (total (pharyngo)-laryngectomy). Neo-adjuvant chemotherapy with 5-FU/platinum salt can be proposed in an attempt to preserve the larynx. The level of the response to chemotherapy ran...
Main Authors: | K. Aubry, J.L. Labourey, J.P. Bessède, N. Tubiana-Mathieu, M. Rigaud |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2008-01-01
|
Series: | Clinical Medicine Insights: Oncology |
Online Access: | https://doi.org/10.1177/117955490800200101 |
Similar Items
-
Microsatellite instability in colorectal cancer and association with thymidylate synthase and dihydropyrimidine dehydrogenase expression
by: Kruhøffer Mogens, et al.
Published: (2009-01-01) -
Alternative chemoradiotherapy in anal carcinoma patients with mutations in thymidylate synthase and dihydropyrimidine dehydrogenase genes
by: MW Saif, et al.
Published: (2021-07-01) -
Thymidylate synthase inhibitors for thoracic tumors
by: Peters Godefridus J., et al.
Published: (2013-06-01) -
Trichinella pseudospiralis vs. T. spiralis thymidylate synthase gene structure and T. pseudospiralis thymidylate synthase retrogene sequence
by: Elżbieta Jagielska, et al.
Published: (2014-04-01) -
Dynamic allostery in substrate binding by human thymidylate synthase
by: Jeffrey P Bonin, et al.
Published: (2022-10-01)